John Dunne, Director at the UK Vaping Industry Association (UKVIA):
“While we welcome any research which can assist people in staying safe during the Covid-19 pandemic, the UKVIA is disappointed by the Stanford-led study which appears to dismiss the vital harm-reduction role of vaping for smokers, and draws disproportionate conclusions.
“The UK does not have the issue of youth vaping observed in some other countries. In fact, less than 0.1% of 11- to 18-year-olds who have never smoked are current vapers in the UK, according to Action on Smoking and Health (ASH).
“There is also no scientific evidence that points to a link between smoking, vaping and Covid-19. We look forward to seeing the peer review of this study.
“It is also somewhat reckless in stating that vapers are putting themselves “at risk of Covid-19” by vaping. Vaping products are designed only for smokers and ex-smokers to help them quit conventional cigarettes, which is the most positive action someone can take to improve their health.”
